These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Modern multiple sclerosis treatment - what is approved, what is on the horizon. Pilz G; Wipfler P; Ladurner G; Kraus J Drug Discov Today; 2008 Dec; 13(23-24):1013-25. PubMed ID: 18775508 [TBL] [Abstract][Full Text] [Related]
4. Concepts of induction and escalation therapy in multiple sclerosis. Rieckmann P J Neurol Sci; 2009 Feb; 277 Suppl 1():S42-5. PubMed ID: 19200866 [TBL] [Abstract][Full Text] [Related]
5. Management of worsening multiple sclerosis with mitoxantrone: a review. Fox EJ Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460 [TBL] [Abstract][Full Text] [Related]
7. Toward the development of rational therapies in multiple sclerosis: what is on the horizon? Hemmer B; Hartung HP Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020 [TBL] [Abstract][Full Text] [Related]
8. A clinician's approach to modulate disease activity in MS. Cook SD Rev Neurol Dis; 2005; 2(3):117-23. PubMed ID: 16400310 [TBL] [Abstract][Full Text] [Related]
9. Knowns and unknowns in the future of multiple sclerosis treatment. Stüve O J Neurol Sci; 2009 Dec; 287 Suppl 1():S30-6. PubMed ID: 20106346 [TBL] [Abstract][Full Text] [Related]
10. Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta. Comi G Clin Ther; 2009 Jun; 31(6):1142-57. PubMed ID: 19695384 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory drug treatment in multiple sclerosis. Aharoni R Expert Rev Neurother; 2010 Sep; 10(9):1423-36. PubMed ID: 20819013 [TBL] [Abstract][Full Text] [Related]
12. The future of multiple sclerosis treatment. Cohen JA J Neurol Sci; 2009 Feb; 277 Suppl 1():S55-61. PubMed ID: 19200869 [TBL] [Abstract][Full Text] [Related]
13. Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit. Carroll WM Mult Scler; 2009 Aug; 15(8):951-8. PubMed ID: 19465446 [TBL] [Abstract][Full Text] [Related]
15. New drug therapies for multiple sclerosis. Mangas A; Coveñas R; Geffard M Curr Opin Neurol; 2010 Jun; 23(3):287-92. PubMed ID: 20414110 [TBL] [Abstract][Full Text] [Related]
16. Daclizumab treatment for multiple sclerosis. Kim SE Pharmacotherapy; 2009 Feb; 29(2):227-35. PubMed ID: 19170591 [TBL] [Abstract][Full Text] [Related]
17. Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation? Lugaresi A Expert Opin Drug Deliv; 2009 Sep; 6(9):995-1002. PubMed ID: 19637982 [TBL] [Abstract][Full Text] [Related]
18. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities. Stuart WH Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719 [TBL] [Abstract][Full Text] [Related]
19. Predicting and preventing the future: actively managing multiple sclerosis. Hutchinson M Pract Neurol; 2009 Jun; 9(3):133-43, discussion 144. PubMed ID: 19448055 [TBL] [Abstract][Full Text] [Related]